Contemporary approaches to the search for active drugs and chemotherapy regimens for tuberculosis treatment

Contemporary approaches to the search for active drugs and chemotherapy regimens for tuberculosis treatment

The article analyzes scientific publications (37 articles) devoted to phthisiology, clinical pharmacology of antimicrobial agents, laboratory methods for evaluating the effectiveness and safety of various regimens of tuberculosis chemotherapy caused by resistant strains of M. tuberculosis.It tells a...

Full description

Bibliographic Details
Main Authors:	T. K. Lugovkinа, S. N. Skornyakov, E. I. Kildyushevа, E. A. Egorov
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2020-07-01
Series:	Туберкулез и болезни лёгких
Subjects:	phthisiology antibiotic resistance <i>m. tuberculosis</i>
Online Access:	https://www.tibl-journal.com/jour/article/view/1437

Similar Items

Defects in the statistical accounting of patients with tuberculosis with its multidrug-resistant pathogen
by: V. B. Galkin
Published: (2015-02-01)

Implementation of professional development programs in phthisiology using the technology of distance training within additional professional education system
by: O. V. Filinyuk, et al.
Published: (2019-05-01)

Efficacy of funding of tuberculosis control activities from mandatory health insurance fund
by: S. A. Sterlikov, et al.
Published: (2019-05-01)

Phithisiology status as a specialization in the representation of medical students
by: Alenin P.N., et al.
Published: (2015-09-01)

ASPECTS OF RUSSIA'S DRUG SOVEREIGNTY IN TERMS OF ANTI-TUBERCULOSIS DRUGS PRODUCTION
by: I. V. Vladimirov, et al.
Published: (2022-08-01)

EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS
by: S. E. Borisov, et al.
Published: (2018-04-01)

Basic foundations of phthisiology professionalization in the assessment of experts
by: Alenin P.N., et al.
Published: (2016-12-01)

Phthisiology questions in International Congress of the European Respiratory Society 2019: achievement of the Ukrainian scientists
by: M. I. Gumeniuk, et al.
Published: (2019-12-01)

Tuberculosis control in those receiving genetically engineering biologic drugs in Chelyabinsk Region
by: V. V. Tinkova, et al.
Published: (2019-09-01)

Clinical features of the course of tuberculous meningitis in HIV-infected patients
by: Irina Y. Babaeva, et al.
Published: (2023-09-01)

COMPLEMENTARITY OF MEDICAL, SOCIAL AND PSYCHOLOGICAL CARE IN TUBERCULOSIS CONTROL (AS REPORTED BY DOCTORS AND PATIENTS)
by: S. A. Yudin, et al.
Published: (2017-04-01)

Tools to Alleviate the Drug Resistance in <i>Mycobacterium tuberculosis</i>
by: Ali A. Rabaan, et al.
Published: (2022-10-01)

A Clinical Case of Extensive Drug Resistant Pulmonary Tuberculosis Using an Endobronchial Valve. Analysis of Errors in the Choice of Chemotherapy Regimen
by: I. A. Burmistrovа, et al.
Published: (2021-11-01)

Efficacy and safety of chemotherapy regimens with bedaquiline in patients with respiratory tuberculosis: immediate and final results
by: S. E. Borisov, et al.
Published: (2019-05-01)

Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis
by: А. V. Kukurika
Published: (2022-10-01)

Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
by: Antonia Molloy, et al.
Published: (2021-11-01)

Tolerability of individual chemotherapy regimens in children suffering from respiratory tuberculosis and exposed to multiple and extensive drug resistant tuberculosis
by: M. F. Gubkinа, et al.
Published: (2021-04-01)

The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives
by: Morgan Maiolini, et al.
Published: (2020-06-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

DNA Methyltransferase HsdM Induce Drug Resistance on <i>Mycobacterium tuberculosis</i> via Multiple Effects
by: Hongqian Chu, et al.
Published: (2021-12-01)

Universal Lineage-Independent Markers of Multidrug Resistance in <i>Mycobacterium tuberculosis</i>
by: Hleliwe Hlanze, et al.
Published: (2024-06-01)

Extra-pulmonary tuberculosis in Saudi Arabia
by: Al-Otaibi Fawzia, et al.
Published: (2010-04-01)

DRUG RESISTANCE OF STRAINS OF M. TUBERCULOSIS, ISOLATED FROM PULMONARY TUBERCULOSIS PATIENTS IN VLADIMIR REGION IN 2013
by: E. S. Dyuzhik, et al.
Published: (2015-10-01)

Pattern and drug sensitivity of non-specific bacterial population in tuberculosis patients with multiple drug resistance
by: A. V. Lavrinenko, et al.
Published: (2019-10-01)

The Epistatic Landscape of Antibiotic Resistance of Different Clades of <i>Mycobacterium tuberculosis</i>
by: Dillon Muzondiwa, et al.
Published: (2021-07-01)

ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2018-07-01)

Testing Susceptibility of <i>M. tuberculosis</i> to Second Line Anti-Tuberculosis Drugs Using the XDR Test in Clinical Trials and International Professional Testing Cycles
by: L. V. Domotenko, et al.
Published: (2021-09-01)

An Exploratory Review of the Potential of Lytic Proteins and Bacteriophages for the Treatment of Tuberculosis
by: Sibongile Mtimka, et al.
Published: (2024-03-01)

Challenges in the development of drugs for the treatment of tuberculosis
by: Adeeb Shehzad, et al.

Challenges in the development of drugs for the treatment of tuberculosis
by: Adeeb Shehzad, et al.
Published: (2013-02-01)

Efficacy of standard chemotherapy regimens in children and adolescents suffering from respiratory tuberculosis
by: E. F. Luginova, et al.
Published: (2020-12-01)

The evolving biology of Mycobacterium tuberculosis drug resistance
by: Richard M. Jones, et al.
Published: (2022-10-01)

Common Variants in the Glycerol Kinase Gene Reduce Tuberculosis Drug Efficacy
by: Michelle M. Bellerose, et al.
Published: (2019-08-01)

Characterization of drug susceptibility of Mycobacterium tuberculosis isolated from new cases of tuberculosis concurrent with HIV infection
by: G. V. Panov, et al.
Published: (2015-02-01)

Heterogeneity of Mycobacterium tuberculosis drug resistance in respect of pharmacokinetics of anti-tuberculosis drugs as a basis for individual treatment regimen
by: S. A. Popov, et al.
Published: (2015-04-01)

SHORT-TERM CHEMOTHERAPY REGIMEN OF MULTIDRUG-RESISTANT TUBERCULOSIS IN THE KYRGYZ REPUBLIC
by: E.V. ZHDANOVA, et al.
Published: (2018-08-01)

Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in M. tuberculosis
by: Andrew I Wong, et al.
Published: (2023-02-01)

Editorial: Factors associated with drug resistance and virulence of Mycobacterium tuberculosis
by: Natalie Eva Nieuwenhuizen, et al.
Published: (2024-12-01)

INDIVIDUAL APPROACHES TO THE CHOICE OF CHEMOTHERAPY REGIMENS FOR RESPIRATORY TUBERCULOSIS IN CHILDREN EXPOSED TO MULTIPLE DRUG RESISTANT TUBERCULOUS INFECTION
by: M. F. Gubkina, et al.
Published: (2016-09-01)

Molecular Evidence of Drug-Resistant Tuberculosis in the Balimo Region of Papua New Guinea
by: Tanya Diefenbach-Elstob, et al.
Published: (2019-02-01)